HomeClinical TopicsFDA approves Gardasil for prevention of anal cancer

FDA approves Gardasil for prevention of anal cancer

The U.S. Food and Drug Administration (FDA) has approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions because of human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years. Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...